Shopping Cart 0
Cart Subtotal
USD 0

Bioasis Technologies Inc (BTI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Bioasis Technologies Inc (BTI) is a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company's transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents across the blood brain barrier. It commercializes its business operations through Cognitest and Transcend names. BTI operates through research institutions and other biotechnology and pharmaceutical companies. The company provides services by conducting research and development with pharmaceutical companies and institutions to advance its technologies. BTI is headquartered in Richmond, British Columbia, Canada.

Bioasis Technologies Inc (BTI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Bioasis Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Bioasis Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 10

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Bioasis Technologies and BioAgilytix Enter into Co-Development Agreement 12

Bioasis Technologies Enters into Agreement with Wuxi Biologics 13

biOasis Technologies Enters into Research Agreement with Brigham and Women's Hospital 14

Bioasis Enters into Collaborative Research Agreement with Brain Canada 15

biOasis Technologies Enters Into Research Agreement With UCB 16

biOasis Technologies Enters Into Research Agreement With Abbott Labs 17

Licensing Agreements 18

Vaccinex Enters into Licensing Agreement with biOasis Technologies 18

Astellas Research Institute of America Enters into License Agreement with biOasis Technologies 19

biOasis Enters Into Licensing Agreement With Medimmune For Transcend Brain Delivery Platform 20

Equity Offering 21

Bioasis Raises USD0.7 Million in Private Placement of Shares 21

Bioasis Technologies Raises USD0.5 Million in Second Tranche of Private Placement of Units 22

biOasis Tech Raises USD3 Million in Private Placement of Units 24

Bioasis Tech Raises Funds through Private Placement of Units 25

biOasis Raises USD1.5 Million in Private Placement of Units 26

biOasis Technologies Completes Private Placement Of Units For USD 2.5 Million 27

Bioasis Technologies Inc-Key Competitors 28

Bioasis Technologies Inc-Key Employees 29

Bioasis Technologies Inc-Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Recent Developments 31

Financial Announcements 31

Jul 30, 2018: Bioasis Technologies announces financial results for three months ended May 31, 2018 31

Jun 26, 2018: Bioasis Technologies announces financial results for fiscal 2018 32

Jan 29, 2018: Bioasis Technologies announces financial results for three months ended November 30, 2017 33

Corporate Communications 34

Jul 27, 2018: Bioasis welcomes John E. Curran & David M. Wurzer to the company's board of directors 34

May 14, 2018: Bioasis announces intention to pursue NASDAQ listing 35

Mar 26, 2018: Bioasis Technologies Appoints Caroline Hill As senior vice president, Research & Development Operations 36

Mar 21, 2018: Bioasis Appoints Deborah Rathjen as Chair of the Board of Directors 37

Dec 04, 2017: Bioasis Implements Transition Plan for Its Board of Directors 38

Oct 02, 2017: biOasis Appoints Christopher P. Lowe, M.B.A. as Chief Financial Officer and Board Advisor 39

Sep 18, 2017: biOasis Announces Rob Hutchison, Founder, to Retire as Chairman & Board Member 40

Sep 07, 2017: biOasis Announces Formation of Scientific Advisory Board to Advance the Science for the Company's Blood-Brain Barrier Drug Delivery Platform 42

Aug 28, 2017: biOasis Announces Nominees to the Board of Directors, Chairman Transition and Details of its Annual General Meeting of Shareholders 44

Aug 21, 2017: biOasis Appoints Doug Williams, MBA, Executive Vice President, Chief Business Officer 46

Apr 24, 2017: biOasis Appoints Mark Day, Ph.D., as Chief Executive Officer and Director 47

Other Significant Developments 48

Jun 14, 2017: biOasis CEO Dr. Mark Day Releases Details of Corporate Plans in Message to Shareholders 48

Jan 22, 2017: biOasis Provides AGM Update-Expanding The biOasis Deal Flow Pipeline 50

Appendix 52

Methodology 52

About GlobalData 52

Contact Us 52

Disclaimer 52


List Of Figure

List of Figures

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Bioasis Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Bioasis Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Bioasis Technologies Inc, Deals By Therapy Area, 2012 to YTD 2018 9

Bioasis Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 10

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Bioasis Technologies and BioAgilytix Enter into Co-Development Agreement 12

Bioasis Technologies Enters into Agreement with Wuxi Biologics 13

biOasis Technologies Enters into Research Agreement with Brigham and Women's Hospital 14

Bioasis Enters into Collaborative Research Agreement with Brain Canada 15

biOasis Technologies Enters Into Research Agreement With UCB 16

biOasis Technologies Enters Into Research Agreement With Abbott Labs 17

Vaccinex Enters into Licensing Agreement with biOasis Technologies 18

Astellas Research Institute of America Enters into License Agreement with biOasis Technologies 19

biOasis Enters Into Licensing Agreement With Medimmune For Transcend Brain Delivery Platform 20

Bioasis Raises USD0.7 Million in Private Placement of Shares 21

Bioasis Technologies Raises USD0.5 Million in Second Tranche of Private Placement of Units 22

biOasis Tech Raises USD3 Million in Private Placement of Units 24

Bioasis Tech Raises Funds through Private Placement of Units 25

biOasis Raises USD1.5 Million in Private Placement of Units 26

biOasis Technologies Completes Private Placement Of Units For USD 2.5 Million 27

Bioasis Technologies Inc, Key Competitors 28

Bioasis Technologies Inc, Key Employees 29

Bioasis Technologies Inc, Other Locations 30

Bioasis Technologies Inc, Subsidiaries 30

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Bioasis Technologies Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Bioasis Technologies Inc (BTI) is a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company's transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents across the blood brain barrier. It commercializes its business operations through Cognitest and Transcend names. BTI operates through research institutions and other biotechnology and pharmaceutical companies. The company provides services by conducting research and development with pharmaceutical companies and institutions to advance its technologies. BTI is headquartered in Richmond, British Columbia, Canada.

Bioasis Technologies Inc (BTI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Bioasis Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Bioasis Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 10

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Bioasis Technologies and BioAgilytix Enter into Co-Development Agreement 12

Bioasis Technologies Enters into Agreement with Wuxi Biologics 13

biOasis Technologies Enters into Research Agreement with Brigham and Women's Hospital 14

Bioasis Enters into Collaborative Research Agreement with Brain Canada 15

biOasis Technologies Enters Into Research Agreement With UCB 16

biOasis Technologies Enters Into Research Agreement With Abbott Labs 17

Licensing Agreements 18

Vaccinex Enters into Licensing Agreement with biOasis Technologies 18

Astellas Research Institute of America Enters into License Agreement with biOasis Technologies 19

biOasis Enters Into Licensing Agreement With Medimmune For Transcend Brain Delivery Platform 20

Equity Offering 21

Bioasis Raises USD0.7 Million in Private Placement of Shares 21

Bioasis Technologies Raises USD0.5 Million in Second Tranche of Private Placement of Units 22

biOasis Tech Raises USD3 Million in Private Placement of Units 24

Bioasis Tech Raises Funds through Private Placement of Units 25

biOasis Raises USD1.5 Million in Private Placement of Units 26

biOasis Technologies Completes Private Placement Of Units For USD 2.5 Million 27

Bioasis Technologies Inc-Key Competitors 28

Bioasis Technologies Inc-Key Employees 29

Bioasis Technologies Inc-Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Recent Developments 31

Financial Announcements 31

Jul 30, 2018: Bioasis Technologies announces financial results for three months ended May 31, 2018 31

Jun 26, 2018: Bioasis Technologies announces financial results for fiscal 2018 32

Jan 29, 2018: Bioasis Technologies announces financial results for three months ended November 30, 2017 33

Corporate Communications 34

Jul 27, 2018: Bioasis welcomes John E. Curran & David M. Wurzer to the company's board of directors 34

May 14, 2018: Bioasis announces intention to pursue NASDAQ listing 35

Mar 26, 2018: Bioasis Technologies Appoints Caroline Hill As senior vice president, Research & Development Operations 36

Mar 21, 2018: Bioasis Appoints Deborah Rathjen as Chair of the Board of Directors 37

Dec 04, 2017: Bioasis Implements Transition Plan for Its Board of Directors 38

Oct 02, 2017: biOasis Appoints Christopher P. Lowe, M.B.A. as Chief Financial Officer and Board Advisor 39

Sep 18, 2017: biOasis Announces Rob Hutchison, Founder, to Retire as Chairman & Board Member 40

Sep 07, 2017: biOasis Announces Formation of Scientific Advisory Board to Advance the Science for the Company's Blood-Brain Barrier Drug Delivery Platform 42

Aug 28, 2017: biOasis Announces Nominees to the Board of Directors, Chairman Transition and Details of its Annual General Meeting of Shareholders 44

Aug 21, 2017: biOasis Appoints Doug Williams, MBA, Executive Vice President, Chief Business Officer 46

Apr 24, 2017: biOasis Appoints Mark Day, Ph.D., as Chief Executive Officer and Director 47

Other Significant Developments 48

Jun 14, 2017: biOasis CEO Dr. Mark Day Releases Details of Corporate Plans in Message to Shareholders 48

Jan 22, 2017: biOasis Provides AGM Update-Expanding The biOasis Deal Flow Pipeline 50

Appendix 52

Methodology 52

About GlobalData 52

Contact Us 52

Disclaimer 52


List Of Figure

List of Figures

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Bioasis Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Bioasis Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Bioasis Technologies Inc, Deals By Therapy Area, 2012 to YTD 2018 9

Bioasis Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 10

Bioasis Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Bioasis Technologies and BioAgilytix Enter into Co-Development Agreement 12

Bioasis Technologies Enters into Agreement with Wuxi Biologics 13

biOasis Technologies Enters into Research Agreement with Brigham and Women's Hospital 14

Bioasis Enters into Collaborative Research Agreement with Brain Canada 15

biOasis Technologies Enters Into Research Agreement With UCB 16

biOasis Technologies Enters Into Research Agreement With Abbott Labs 17

Vaccinex Enters into Licensing Agreement with biOasis Technologies 18

Astellas Research Institute of America Enters into License Agreement with biOasis Technologies 19

biOasis Enters Into Licensing Agreement With Medimmune For Transcend Brain Delivery Platform 20

Bioasis Raises USD0.7 Million in Private Placement of Shares 21

Bioasis Technologies Raises USD0.5 Million in Second Tranche of Private Placement of Units 22

biOasis Tech Raises USD3 Million in Private Placement of Units 24

Bioasis Tech Raises Funds through Private Placement of Units 25

biOasis Raises USD1.5 Million in Private Placement of Units 26

biOasis Technologies Completes Private Placement Of Units For USD 2.5 Million 27

Bioasis Technologies Inc, Key Competitors 28

Bioasis Technologies Inc, Key Employees 29

Bioasis Technologies Inc, Other Locations 30

Bioasis Technologies Inc, Subsidiaries 30

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Bioasis Technologies Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.